Article Information
PubMed
History
- Published online December 12, 2011.
Article Versions
- Latest version (November 7, 2011 - 09:23).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2011 Canadian Medical Association or its licensors
Author Information
- Naomi Gronich, MD⇓,
- Idit Lavi, MSc,
- Gad Rennert, MD PhD
- From the Department of Community Medicine and Epidemiology (Gronich, Lavi, Rennert), Carmel Medical Center and Bruce Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa; and the Department of Epidemiology and Disease Prevention (Rennert), Office of Chief Physician, Clalit Health Services Headquarters, Tel Aviv, Israel
- Correspondence to:
Dr. Naomi Gronich, gronichn{at}clalit.org.il
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study
Jump to section
Related Articles
Cited By...
- FSRH Guideline (January 2019) Combined Hormonal Contraception
- Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
- Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
- Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databases
- Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
- Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases
- Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10